![Matt Vaughan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Posizioni attive di Matt Vaughan
Società | Posizione | Inizio | Fine |
---|---|---|---|
Amplifybio LLC
![]() Amplifybio LLC Miscellaneous Commercial ServicesCommercial Services Amplifybio LLC is a drug development and commercialization partner that provides preclinical toxicology, safety, and pharmacology testing services to advance therapeutics for the betterment of human health. The company is based in West Jefferson, OH and has subsidiaries in the United States. The company was launched out of Battelle in 2021 and has since expanded its services to include R&D and drug characterization services, as well as customizable manufacturing suites for lease. Amplifybio's clients benefit from decades of experience in drug development, safety testing, and manufacturing support services, which help to reduce risks, timelines, and costs of bringing life-saving cures to patients. The company was founded in 2021, and the CEO is J. Kelly Ganjei. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Matt Vaughan
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Posizioni
Director/Board Member | 1 |
Settori
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Amplifybio LLC
![]() Amplifybio LLC Miscellaneous Commercial ServicesCommercial Services Amplifybio LLC is a drug development and commercialization partner that provides preclinical toxicology, safety, and pharmacology testing services to advance therapeutics for the betterment of human health. The company is based in West Jefferson, OH and has subsidiaries in the United States. The company was launched out of Battelle in 2021 and has since expanded its services to include R&D and drug characterization services, as well as customizable manufacturing suites for lease. Amplifybio's clients benefit from decades of experience in drug development, safety testing, and manufacturing support services, which help to reduce risks, timelines, and costs of bringing life-saving cures to patients. The company was founded in 2021, and the CEO is J. Kelly Ganjei. | Commercial Services |
- Borsa valori
- Insiders
- Matt Vaughan
- Esperienza